Search

Establishing a medical device company: an ENTrepreneur’s experience

In 2004, while I was suturing the mucopericondrial flaps for a septoplasty, I thought to myself, “there must be an easier and faster way of doing this”. Even though I had no formal training in business or medical device development,...

The doctor – pharmaceutical company relationship

‘Which drug rep is taking us out tonight?’ We have heard this phrase uttered at conferences since meetings began, but as Dylan said ‘those times they are a changing’ thanks to the Association of the British Pharmaceutical Industry (ABPI) and...

In search of courage; transition 
into Army

In search of courage. Well, that is how it all started. I was fairly advanced in surgical training not to mention age, when I decided to join the Territorial Army (TA). My peers, on hearing this couldn’t decide whether I...

A patient-centred approach from the patient’s point of view

Seeking help for hearing loss is often a big step for patients. Shari Eberts, a hearing health advocate living with hearing loss, explains why, and gives us her five top tips to improve patient-centred care in such cases. Sensorineural hearing...

Enhancing and extending hearing care using Ida Telecare

Tele-audiology has been on our radar for a long while, and evidence shows that its application in clinical practice is beneficial to both patients and clinicians. Cherilee Rutherford discusses the benefits and gives an overview of the freely-available tools developed...

Current management of unilateral sporadic vestibular schwannoma

Vestibular schwannoma is the commonest tumour of the cerebellopontine angle (80%) and accounts for around 8% of all intracranial tumours. The commonest primary presenting symptoms are audio vestibular. Hearing health professionals are often the first contact for patients with potential symptoms of vestibular schwannoma, with the majority then being seen and diagnosed by otorhinolaryngologists.

Lenire as a clinical tool for treatment of tinnitus

Lenire offers a promising but varied solution for tinnitus relief. Peter Byrom shares insights on its effectiveness, challenges and patient outcomes. I have been involved in tinnitus support for at least 20 years, including a stint on the then British...

Cartilage conduction hearing aids: the third pathway for sound transmission and its application

Air-conduction and bone-conduction are familiar terms; now enter ‘cartilage conduction’. This new term offers a novel approach sound transmission. Hiroshi Hosoi explains the concept and proposes some future applications. The new sound pathway ‘cartilage conduction’ can provide various types of...

The changing landscape for hearing loss therapeutics: novel advances of gene and cell therapies

Recent years have seen advances in hearing loss therapeutics, with novel treatments trialled in humans, and others nearing promising first-in-kind clinical trials. First successful clinical trials for a specific form of genetic hearing loss Very exciting news has emerged in...

Enhancing care for adults with auditory neuropathy spectrum disorder

It’s time to improve and personalise care for adults with ANSD. Knowing the lesion site could open up treatment opportunities like cochlear implants or new cell therapies. Auditory neuropathy spectrum disorder (ANSD) comprises a group of hearing disorders characterised by...

Making audiology work during COVID-19 and beyond

‘New normal’ is another phrase that has become synonymous with this pandemic. In this article, consideration for ‘low-touch’ and ‘no touch’ audiological pathways are described for adoption as the ‘new normal’ for hearing healthcare. The COVID-19 crisis has ushered in...